Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection

This article was originally published by Christopher M. Holman in Intellectual Property Watch under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (http://creativecommons.org/licenses/by-nc-sa/4.0/). Despite the impor…


FDA Approval of New Drugs One of Many Goals for Drug Manufacturers

The US pharmaceutical market, together with those of Canada and Mexico, make more than half the global pharmaceutical. The US alone is the world’s largest and it represents 45 percent of…
The post FDA Approval of New Drugs One of Many Goals for Drug Ma…


Securing the Right Space for Your Biotech Start-up

This is a guest post by Steven Lee, Senior Scientist in the Life Sciences Group at Environmental Health & Engineering (EH&E) Once you have the idea and the funding for a biotech start-up, you may think the biggest challenges are behind you. However, without proper planning and considerations, the environment you choose for your laboratory facility […]


Demystifying Microbiome Probiotics (Supplements)

This is a guest post from Susan K Finston, President of Finston Consulting.  This is the latest entry in an occasional series tracking the microbiome.  I first wrote about the potential of the microbiome for human health in October 2015.  At that time there was little awareness of the significance and potential of the human microbiome.  […]


Evidence of insufficient quality of reporting in patent landscapes in the life sciences

This article was originally published by James A Smith, Zeeshaan Arshad, Hannah Thomas, Andrew J Carr & David A Brindley in Nature Biotechnology v35, pp 210–214 (2017) under a creative…
The post Evidence of insufficient quality of reporting in patent l…


Indian pharmaceutical patent prosecution: The changing role of Section 3(d)

This paper was originally published by Bhaven N. Sampat and Kenneth C. Shadlen in PLoS ONE 13(4): e0194714 under a Creative Commons license. Abstract India, like many developing countries, only recently…
The post Indian pharmaceutical patent prosecutio…


Diffusion, convergence and influence of pharmaceutical innovations: a comparative study of Chinese and U.S. patents

This paper was originally published by Qiaolei Jiang and Chunjuan Luan in Globalization and Health 2018 14:92 under a Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/). Abstract Background Despite the …


How Long Do Drug Patents Last?

Patents filed since 1995 last for 20 years from the date of patent application filing. This is true for “utility” patents, but the terms for certain other, less common types…
The post How Long Do Drug Patents Last? appeared first on DrugPatentWatch – M…


Drug Patent Expirations and Generic Entry Opportunities 2018-2019

In response to requests for a simple generic entry opportunity date for drugs we have leveraged our 1-step dominant patent identification method to produce a continuously-updated list of upcoming patent expirations and generic entry opportunity dates. The list is licensed under a Creative Commons Attribution 4.0 International License, which means you are free to republish it, […]


Can formulation and drug delivery reduce attrition during drug discovery and development—review of feasibility, benefits and challenges

This article was originally published by Basavaraj S, Guru V. Betageri in Acta Pharmaceutica Sinica B Volume 4, Issue 1, February 2014, Pages 3-17 under a Creative Commons License. Abstract Drug discovery and development…
The post Can formulation and d…


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: